The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Difficult/therapy‐resistant asthmaThe need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies
Open accessAbstract
A Task Force supported by the European Respiratory Society was set up in 1997 in order to address the major issues relevant to difficult/therapy-resistant asthma.Although the group of patients involved is small in comparison to the high numbers of patients with asthma, these patients consume a significant proportion of medical resources in terms of both time and money [1].The major issues facing the Task Force were how to define "difficult asthma", how the patient with difficult asthma should be evaluated, the pathophysiological mechanisms underlying difficult asthma and the treatments available.The Task Force also concerned itself with defining the areas of research necessary to bring about a greater understanding of the causes of difficult asthma and novel treatments.The document resulting from this Task Force represents a consensus of different opinions, which will form the basis for further research. Formulating the definitionA large number of terms are used by clinicians when referring to asthmatic patients who have "difficult to treat" disease: difficult acute, difficult chronic, chronic severe, acute severe, therapy-resistant, difficult to control, corticosteroid-resistant or corticosteroid-dependent, symptomatic, life-threatening, and fatal.An encompassing inclusive rather than exclusive definition was sought and the use of the term "difficult/therapy-resistant asthma" was adopted to include all such cases of asthma of all age groups.Since wheezing disorders in preschool children are poorly characterized, this report specifically excludes children below the age of 5 yrs.Response to therapy is included in this concept and will have research implications.It was accepted that the definition needed to be inclusive, although losing some precision, but it was also recognized that its This position document of the European Respiratory Society was officially adopted by the ERS Executive Committee.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Corren, J., Adinoff, A. D., Buchmeier, A. D., & Irvin, C. G. (1992) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(92)90079-h · Cited by 290
Cited by
International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
Chung, K. F., Wenzel, S. E., Brozek, J. L., Bush, A., Castro, M., Sterk, P. J., Adcock, I. M., Bateman, E. D., Bel, E. H., Bleecker, E. R., et al. (2014) · European Respiratory Journal · doi:10.1183/09031936.00202013 · Cited by 3,926
The link between fungi and severe asthma: A summary of the evidence
Denning, D. W., O'Driscoll, B. R., Hogaboam, C. M., Bowyer, P., & Niven, R. M. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00074705 · Cited by 824
Bousquet, J., Mantzouranis, E., Cruz, A. A., Aït-Khaled, N., Baena-Cagnani, C. E., Bleecker, E. R., Brightling, C. E., Burney, P., Bush, A., Busse, W. W., et al. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.07.019 · Cited by 741
Risk factors of frequent exacerbations in difficult-to-treat asthma
ten Brinke, A., Sterk, P. J., Masclee, A. A. M., Spinhoven, P., Schmidt, J. T., Zwinderman, A. H., Rabe, K. F., & Bel, E. H. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00037905 · Cited by 490
Role for NLRP3 Inflammasome–mediated, IL-1β–Dependent Responses in Severe, Steroid-Resistant Asthma
Kim, R. Y., Pinkerton, J. W., Essilfie, A. T., Robertson, A. A. B., Baines, K. J., Brown, A. C., Mayall, J. R., Ali, M. K., Starkey, M. R., Hansbro, N. G., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201609-1830oc · Cited by 435
Metadata
- Authors
- Ers Task Force on Difficult/therapy-Resistant Asthma, & Members of the Task Force: K.F. Chung and P. Godard (co-chairmen), E. A.
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 1999-05
- Volume
- 13
- Issue
- 5
- Pages
- 1198
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W1914519050
- Cited by
- 351
- References
- 1
- FWCI
- 3.81
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Difficult/therapy‐resistant asthmaThe need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. https://app.cochat.ai/papers/10.1034/j.1399-3003.1999.13e43.x
- The paper
- Ers Task Force on Difficult/therapy-Resistant Asthma, & Members of the Task Force: K.F. Chung and P. Godard (co-chairmen), E. A. (1999). Difficult/therapy‐resistant asthmaThe need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. European Respiratory Journal. https://doi.org/10.1034/j.1399-3003.1999.13e43.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.